Back
MoonLake Immunotherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
MLTX
MoonLake Immunotherapeutics
Last Price:
$13.38
Seasonality Move:
20.98%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.22 | Sell |
| 20-day SMA: | 13.97 | Sell |
| 50-day SMA: | 12.01 | Buy |
| 200-day SMA: | 35.93 | Sell |
| 8-day EMA: | 14 | Sell |
| 20-day EMA: | 13.87 | Sell |
| 50-day EMA: | 16.63 | Sell |
| 200-day EMA: | 32.12 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 46.17 | Sell |
| Chaikin Money Flow: | 481662 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13 - 14.6) | Sell |
| Bollinger Bands (100): | (7.72 - 50.7) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 13.39 while MLTX 8-day simple moving average is 14.22, which is a Sell signal.
-
The stock price of MLTX is 13.39 while MoonLake Immunotherapeutics 20-day SMA is 13.97, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day simple moving average is 12.01 while MLTX share price is 13.39, making it a Buy technically.
-
MLTX stock price is 13.39 and MoonLake Immunotherapeutics 200-day simple moving average is 35.93, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
37
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $13.39. The Score for MLTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
948.6M
Price in USD:
13.39
Share Volume:
1.1M
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
62.75
52-Week Low:
5.95
Sell
37
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 13.39 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 13.39 while MLTX 8-day exponential moving average is 14.00, which is a Sell signal.
-
The stock price of MLTX is 13.39 while MoonLake Immunotherapeutics 20-day EMA is 13.87, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 16.63 while MLTX share price is 13.39, making it a Sell technically.
-
MLTX stock price is 13.39 and MoonLake Immunotherapeutics 200-day simple moving average is 32.12, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and a decrease next year of $0.00 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting MoonLake Immunotherapeutics is a Buy
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 46.17, which suggest MoonLake Immunotherapeutics is oversold
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (13 - 14.6), which suggest MoonLake Immunotherapeutics is a Sell
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (7.72 - 50.7), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.